HDL size is more accurate than HDL cholesterol to predict carotid subclinical atherosclerosis in individuals classified as low cardiovascular risk.

HDL size is more accurate than HDL cholesterol to predict carotid subclinical atherosclerosis in individuals classified as low cardiovascular risk.

Misclassification of patients as low cardiovascular risk (LCR) remains a major concern and challenges the efficacy of traditional risk markers. Due to its strong association with cholesterol acceptor capacity, high-density lipoprotein (HDL) size has been appointed as a potential risk marker. Hence,...

Full description

Bibliographic Details
Main Authors:	Eliane Soler Parra, Natalia Baratella Panzoldo, Vanessa Helena de Souza Zago, Daniel Zanetti Scherrer, Fernanda Alexandre, Jamal Bakkarat, Valeria Sutti Nunes, Edna Regina Nakandakare, Eder Carlos Rocha Quintão, Wilson Nadruz, Eliana Cotta de Faria, Andrei C Sposito
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4254940?pdf=render

Similar Items

Associação Positiva entre Autoanticorpos contra LDL Oxidada e HDL-C: Um Novo Mecanismo para Cardioproteção de HDL?
by: Carla Evelyn Coimbra Nunez, et al.
Published: (2022-09-01)

The I405V and Taq1B polymorphisms of the CETP gene differentially affect sub-clinical carotid atherosclerosis
by: Parra Eliane, et al.
Published: (2012-10-01)

Very low HDL levels: clinical assessment and management
by: Isabella Bonilha, et al.
Published: (2023-01-01)

The role of dysfunctional HDL in atherosclerosis
by: Mohamad Navab, et al.
Published: (2009-01-01)

HDL, lipid peroxidation, and atherosclerosis1
by: Baohai Shao, et al.
Published: (2009-04-01)

HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis
by: Beatriz Tejera-Segura, et al.
Published: (2017-05-01)

HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: the Chicago Healthy Aging Study
by: R.Kannan Mutharasan, et al.
Published: (2017-03-01)

Total cholesterol/HDL cholesterol ratio and monocyte/HDL cholesterol ratio are related with subclinical hypothyroidism in polycystic ovary syndrome
by: Cakir Isil, et al.
Published: (2021-09-01)

The Association between HDL-C and Subclinical Atherosclerosis Depends on CETP Plasma Concentration: Insights from the IMPROVE Study
by: Gualtiero I. Colombo, et al.
Published: (2021-03-01)

Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
by: Reza Fadaei, et al.
Published: (2018-08-01)

Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
by: Sara Karami, et al.
Published: (2021-10-01)

Alterations in LDL and HDL after an ischemic stroke associated with carotid atherosclerosis are reversed after 1 year‡
by: Núria Puig, et al.
Published: (2025-02-01)

A reduction of CETP activity, not an increase, is associated with modestly impaired postprandial lipemia and increased HDL-Cholesterol in adult asymptomatic women
by: de Faria Eliana C, et al.
Published: (2011-05-01)

HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis
by: Belinda A. Di Bartolo, et al.
Published: (2021-01-01)

Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
by: Veronika Vyletelová, et al.
Published: (2022-10-01)

Zymosan phagocytosis by mouse peritoneal macrophages is increased by apoHDL- and not by intact HDL-covered particles
by: M.D.T. Carvalho, et al.
Published: (2000-03-01)

HDL-Mimetic PLGA Nanoparticle To Target Atherosclerosis Plaque Macrophages
by: Sanchez-Gaytan, Brenda L., et al.
Published: (2016)

Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis
by: Monique F. M. Santana, et al.
Published: (2020-09-01)

Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis
by: Neelam Srivastava, et al.
Published: (2018-09-01)

Comparação das frações HDL e LDL colesterol como fatores de risco para a aterosclerose carotídea Comparative study of HDL and LDL cholesterol as risk factors for carotid atherosclerosis
by: Rubens José Gagliardi, et al.
Published: (1995-12-01)

Non-HDL-C/HDL-C ratio is associated with carotid plaque stability in general population: A cross-sectional study
by: Anran Wang, et al.
Published: (2022-09-01)

Evaluation of LDL-Cholesterol / HDL-Cholesterol Ratio as Predictor of Dyslipidemia in Subclinical Hypothyroidism
by: Smita S. Kottagi, et al.
Published: (2014-01-01)

Unraveling the Complexity of HDL Remodeling: On the Hunt to Restore HDL Quality
by: Leonie Schoch, et al.
Published: (2021-07-01)

Effect of HDL composition and particle size on the resistance of HDL to the oxidation
by: Jauhiainen Matti, et al.
Published: (2010-09-01)

Beyond HDL-cholesterol increase: phospholipid enrichment and shift from HDL3 to HDL2 in alcohol consumers
by: Christian Schäfer, et al.
Published: (2007-07-01)

TG/HDL Ratio: A marker for insulin resistance and atherosclerosis in prediabetics or not?
by: Ajay Chauhan, et al.
Published: (2021-01-01)

HDL-apoA-I exchange: rapid detection and association with atherosclerosis.
by: Mark S Borja, et al.
Published: (2013-01-01)

The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?
by: Menno Vergeer, et al.
Published: (2010-08-01)

Triglyceride/HDL-Cholesterol Ratio as an Index of Intracranial Atherosclerosis in Nonstroke Individuals
by: Min-Hee Woo, et al.
Published: (2021-01-01)

The LDL-HDL profile determines the risk of atherosclerosis: a mathematical model.
by: Wenrui Hao, et al.
Published: (2014-01-01)

ANGPTL3 is a novel HDL component that regulates HDL function
by: Longyan Yang, et al.
Published: (2024-03-01)

The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
by: Dustin Chernick, et al.
Published: (2020-09-01)

HDL-Related Parameters and COVID-19 Mortality: The Importance of HDL Function
by: Julia T. Stadler, et al.
Published: (2023-11-01)

Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDL
by: John S. Millar, et al.
Published: (2011-01-01)

Association of proportion of the HDL-cholesterol subclasses HDL-2b and HDL-3 and macrovascular events among patients undergoing hemodialysis
by: Wen-Chin Lee, et al.
Published: (2021-01-01)

Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease.
by: Guisong Wang, et al.
Published: (2018-01-01)

Association of the TG/HDL-C and Non-HDL-C/HDL-C Ratios with Chronic Kidney Disease in an Adult Chinese Population
by: Jia Wen, et al.
Published: (2017-12-01)

P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivo.
by: Marine Goffinet, et al.
Published: (2014-01-01)

Vasculitis, Atherosclerosis, and Altered HDL Composition in Heme-Oxygenase-1-Knockout Mice
by: Kazunobu Ishikawa, et al.
Published: (2012-01-01)

Simultaneous Noninvasive Detection and Therapy of Atherosclerosis Using HDL Coated Gold Nanorods
by: Rinat Ankri, et al.
Published: (2022-02-01)